LOGIN
Dexmedetomidine Infusion in Hip Fracture Surgery
March 2022
Dexmedetomidine Infusion in Hip Fracture Surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effect of Dexmedetomidine infusion during hip fracture surgery on hemodynamic parameters and blood loss: A triple-blinded Randomized Clinical Trial.
Injury . 2022 Feb;53(2):551-554.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy six patients undergoing hip fracture surgery under general anesthesia were randomized to receive an intraoperative dexmedetomidine infusion (n=38) or placebo infusion (n=38). The outcomes of interest were blood loss and hemodynamic parameters. The dexmedetomidine group had significantly lower blood loss compared to the placebo group. No differences in hemodynamic parameters were observed b...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.